Elevated ceramide is downstream of altered calcium homeostasis in low serum-induced apoptosis
Two immortalized cell lines, sup (+) and sup (−), derived from mutagenized Syrian hamster embryo cells, were used to study the relationship and temporal order between calcium and ceramide signals during apoptosis. The early preneoplastic cells, termed sup (+), suppress tumorigenicity when hybridized with tumor cells, whereas later-stage sup (−) cells do not. In reduced serum conditions, sup (+) cells cease proliferating and undergo apoptosis; in contrast, sup (−) cells continue slow growth and undergo necrosis. In sup (+) cells, decreased endoplasmic reticulum (ER) calcium occurs 4 h after low serum treatment and precedes apoptosis. Significant elevations in ceramide are observed 16 h after reduced serum treatment of sup (+) cells but are not found in sup (−) cells. Inhibiting ER calcium depletion in low serum-treated sup (+) cells by treating with high levels of calcium prevents both ceramide generation and apoptosis. Conversely, inducing ER calcium depletion in sup (−) cells by treating with low serum plus thapsigargin results in elevated ceramide levels and apoptosis. Furthermore, C6-ceramide treatment induced apoptosis of sup (−) cells in low serum, a condition that does not normally cause apoptosis. C6-ceramide treatment did not induce apoptosis in either sup (+) or sup (−) cells in 10% serum but did cause G2/M arrest. These studies show that ceramide production is downstream of ER calcium release.